family_id
int64 1
1.1k
| family_type
stringclasses 9
values | family_name
stringclasses 590
values | target_id
int64 1
3.29k
| target_name
stringlengths 3
122
| interaction_id
int64 1
90.9k
| interaction_type
stringclasses 10
values | interaction_action
stringclasses 24
values | primary_target
bool 2
classes | affinity_median
float64 0.3
13
⌀ | affinity_units
stringclasses 7
values | ligand_id
int64 1
13.4k
| ligand_name
stringlengths 2
141
| ligand_type
stringclasses 6
values | ligand_approved
bool 2
classes | ligand_approval_source
stringclasses 439
values | pubchem_sid
float64 53.8M
491M
⌀ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
946 | catalytic_receptor | Fc epsilon receptors | 2,933 | Fc fragment of IgE receptor Ia | 84,329 | Agonist | Binding | true | 10 | pKd | 9,557 | IgE heavy chain | Peptide | false | null | 336,446,943 |
946 | catalytic_receptor | Fc epsilon receptors | 2,935 | Fc fragment of IgE receptor II | 84,330 | Agonist | Binding | true | 7 | pKd | 9,557 | IgE heavy chain | Peptide | false | null | 336,446,943 |
314 | catalytic_receptor | GDNF receptor family | 1,743 | GDNF family receptor α1 | 13,485 | null | null | null | null | pKd | 4,851 | [<sup>125</sup>I]GDNF (rat) | Peptide | false | null | 178,101,552 |
314 | catalytic_receptor | GDNF receptor family | 2,977 | GDNF family receptor alpha like | 89,961 | Antagonist | Antagonist | false | 7.13 | pKd | 12,844 | GRASP | Peptide | false | null | 483,123,392 |
314 | catalytic_receptor | GDNF receptor family | 2,977 | GDNF family receptor alpha like | 84,726 | Agonist | Agonist | false | 7.6 | pKd | 9,735 | growth differentiation factor 15 | Peptide | false | null | 354,702,211 |
314 | catalytic_receptor | GDNF receptor family | 2,977 | GDNF family receptor alpha like | 89,959 | Agonist | Agonist | false | 7.26 | pEC50 | 12,843 | LY3463251 | Peptide | false | null | 483,123,391 |
314 | catalytic_receptor | GDNF receptor family | 2,977 | GDNF family receptor alpha like | 89,958 | Agonist | Agonist | false | 8.51 | pKd | 12,843 | LY3463251 | Peptide | false | null | 483,123,391 |
314 | catalytic_receptor | GDNF receptor family | 2,977 | GDNF family receptor alpha like | 89,960 | Agonist | Agonist | false | 6.87 | pEC50 | 12,843 | LY3463251 | Peptide | false | null | 483,123,391 |
311 | catalytic_receptor | IL-10 receptor family | 1,904 | Interferon-λ receptor 1 | 77,198 | Agonist | Agonist | null | null | - | 4,993 | IFN-λ1 | Peptide | false | null | 178,101,690 |
311 | catalytic_receptor | IL-10 receptor family | 1,904 | Interferon-λ receptor 1 | 77,196 | Agonist | Agonist | null | null | - | 4,991 | IFN-λ2 | Peptide | false | null | 178,101,688 |
311 | catalytic_receptor | IL-10 receptor family | 1,904 | Interferon-λ receptor 1 | 77,197 | Agonist | Agonist | null | null | - | 4,992 | IFN-λ3 | Peptide | false | null | 178,101,689 |
311 | catalytic_receptor | IL-10 receptor family | 1,900 | Interleukin-10 receptor | 77,192 | Agonist | Agonist | null | null | - | 4,975 | IL-10 | Peptide | false | null | 178,101,673 |
311 | catalytic_receptor | IL-10 receptor family | 1,901 | Interleukin-20 receptor | 77,193 | Agonist | Agonist | null | null | - | 4,984 | IL-19 | Peptide | false | null | 178,101,681 |
311 | catalytic_receptor | IL-10 receptor family | 1,901 | Interleukin-20 receptor | 77,194 | Agonist | Agonist | null | null | - | 4,986 | IL-20 | Peptide | false | null | 178,101,683 |
311 | catalytic_receptor | IL-10 receptor family | 1,901 | Interleukin-20 receptor | 77,195 | Agonist | Agonist | null | null | - | 4,990 | IL-24 | Peptide | false | null | 178,101,687 |
311 | catalytic_receptor | IL-10 receptor family | 1,903 | Interleukin-22α1/10β heteromer | 88,934 | Agonist | Agonist | false | 9.92 | pEC50 | 12,212 | efmarodocokin alfa | Antibody | false | null | 472,319,332 |
311 | catalytic_receptor | IL-10 receptor family | 1,903 | Interleukin-22α1/10β heteromer | 77,201 | Agonist | Agonist | false | 11.46 | pEC50 | 4,988 | IL-22 | Peptide | false | null | 178,101,685 |
311 | catalytic_receptor | IL-10 receptor family | 1,902 | Interleukin-22α1/20β heteromer | 77,199 | Agonist | Agonist | null | null | - | 4,986 | IL-20 | Peptide | false | null | 178,101,683 |
311 | catalytic_receptor | IL-10 receptor family | 1,902 | Interleukin-22α1/20β heteromer | 77,200 | Agonist | Agonist | null | null | - | 4,990 | IL-24 | Peptide | false | null | 178,101,687 |
311 | catalytic_receptor | IL-10 receptor family | 1,727 | Interleukin 10 receptor, α subunit | 84,288 | Agonist | Agonist | false | null | pEC50 | 4,975 | IL-10 | Peptide | false | null | 178,101,673 |
308 | catalytic_receptor | IL-12 receptor family | 2,292 | Interleukin-12 receptor | 77,186 | Agonist | Agonist | null | null | - | 4,977 | IL-12 | Peptide | false | null | 178,101,675 |
308 | catalytic_receptor | IL-12 receptor family | 2,293 | Interleukin-23 receptor | 77,185 | Agonist | Agonist | null | null | - | 4,978 | IL-23 | Peptide | false | null | 178,101,676 |
313 | catalytic_receptor | IL-17 receptor family | 2,294 | Interleukin-17 receptor | 77,138 | Agonist | Agonist | null | null | - | 4,982 | IL-17A | Peptide | false | null | 178,101,679 |
313 | catalytic_receptor | IL-17 receptor family | 2,294 | Interleukin-17 receptor | 77,140 | Agonist | Agonist | null | null | - | 5,874 | IL-17A/IL-17F | Peptide | false | null | 178,102,498 |
313 | catalytic_receptor | IL-17 receptor family | 2,294 | Interleukin-17 receptor | 77,139 | Agonist | Agonist | null | null | - | 5,873 | IL-17F | Peptide | false | null | 178,102,497 |
313 | catalytic_receptor | IL-17 receptor family | 2,296 | Interleukin-17C receptor | 77,141 | Agonist | Agonist | null | null | - | 5,875 | IL-17C | Peptide | false | null | 178,102,499 |
313 | catalytic_receptor | IL-17 receptor family | 2,295 | Interleukin-25 receptor | 77,143 | Agonist | Agonist | null | null | - | 5,877 | IL-17B | Peptide | false | null | 178,102,501 |
313 | catalytic_receptor | IL-17 receptor family | 2,295 | Interleukin-25 receptor | 77,142 | Agonist | Agonist | null | null | - | 5,876 | IL-25 | Peptide | false | null | 178,102,500 |
313 | catalytic_receptor | IL-17 receptor family | 1,738 | Interleukin 17 receptor A | 81,834 | Antibody | Binding | true | 9.16 | pKd | 7,540 | brodalumab | Antibody | true | Japan (2016), FDA (2017), EMA (2017) | 187,051,841 |
305 | catalytic_receptor | IL-2 receptor family | 1,700 | Interleukin-13 receptor subunit α1 | 88,348 | Antibody | Binding | false | 10.57 | pKd | 11,770 | eblasakimab | Antibody | false | null | 458,923,805 |
305 | catalytic_receptor | IL-2 receptor family | 2,302 | Interleukin-15 receptor | 84,436 | Agonist | Agonist | false | 12.3 | pIC50 | 9,615 | ALT-803 | Antibody | false | null | 340,590,245 |
305 | catalytic_receptor | IL-2 receptor family | 2,302 | Interleukin-15 receptor | 88,087 | Agonist | Agonist | false | 10.81 | pEC50 | 9,615 | ALT-803 | Antibody | false | null | 340,590,245 |
305 | catalytic_receptor | IL-2 receptor family | 2,302 | Interleukin-15 receptor | 77,150 | Agonist | Agonist | false | 11.42 | pIC50 | 4,981 | IL-15 | Peptide | false | null | 178,101,678 |
305 | catalytic_receptor | IL-2 receptor family | 1,702 | Interleukin-15 receptor subunit α | 84,440 | Agonist | Agonist | false | 11.42 | pKd | 4,981 | IL-15 | Peptide | false | null | 178,101,678 |
305 | catalytic_receptor | IL-2 receptor family | 2,297 | Interleukin-2 receptor | 77,153 | Antagonist | Antagonist | null | null | - | 4,861 | AF12198 | Peptide | false | null | 178,101,562 |
305 | catalytic_receptor | IL-2 receptor family | 2,297 | Interleukin-2 receptor | 77,152 | Antagonist | Antagonist | null | null | - | 5,878 | IL-1 receptor antagonist | Peptide | false | null | 178,102,502 |
305 | catalytic_receptor | IL-2 receptor family | 2,297 | Interleukin-2 receptor | 77,144 | Agonist | Agonist | null | null | - | 4,985 | IL-2 | Peptide | true | FDA (1992) | 178,101,682 |
305 | catalytic_receptor | IL-2 receptor family | 2,297 | Interleukin-2 receptor | 77,610 | Antagonist | Antagonist | false | null | - | 5,052 | Ro26-4550 | Synthetic organic | false | null | 178,101,747 |
305 | catalytic_receptor | IL-2 receptor family | 1,695 | Interleukin-2 receptor subunit α | 78,847 | Antibody | Binding | false | null | - | 6,879 | basiliximab | Antibody | true | FDA (1998), EMA (1998) | 178,103,461 |
305 | catalytic_receptor | IL-2 receptor family | 1,695 | Interleukin-2 receptor subunit α | 78,848 | Antibody | Binding | true | 8 | pKd | 6,880 | daclizumab | Antibody | true | FDA FDA (1997), EMA (1999) | 178,103,462 |
305 | catalytic_receptor | IL-2 receptor family | 1,696 | Interleukin-2 receptor subunit β | 87,060 | Agonist | Agonist | false | 5.75 | pKd | 10,659 | bempegaldesleukin | Peptide | false | null | 404,859,106 |
305 | catalytic_receptor | IL-2 receptor family | 2,304 | Interleukin-21 receptor | 77,608 | Agonist | Agonist | null | null | - | 4,987 | IL-21 | Peptide | false | null | 178,101,684 |
305 | catalytic_receptor | IL-2 receptor family | 1,697 | Interleukin-4 receptor subunit α | 81,861 | Antibody | Binding | true | 11.06 | pIC50 | 7,574 | dupilumab | Antibody | true | EMA & FDA (2017) | 223,365,910 |
305 | catalytic_receptor | IL-2 receptor family | 2,298 | Interleukin-4 receptor type I | 77,145 | Agonist | Agonist | null | null | - | 4,996 | IL-4 | Peptide | false | null | 178,101,693 |
305 | catalytic_receptor | IL-2 receptor family | 2,299 | Interleukin-4 receptor type II | 77,147 | Agonist | Agonist | null | null | - | 4,980 | IL-13 | Peptide | false | null | 178,101,677 |
305 | catalytic_receptor | IL-2 receptor family | 2,299 | Interleukin-4 receptor type II | 77,146 | Agonist | Agonist | null | null | - | 4,996 | IL-4 | Peptide | false | null | 178,101,693 |
305 | catalytic_receptor | IL-2 receptor family | 2,300 | Interleukin-7 receptor | 77,148 | Agonist | Agonist | null | null | - | 4,999 | IL-7 | Peptide | false | null | 178,101,696 |
305 | catalytic_receptor | IL-2 receptor family | 1,698 | Interleukin-7 receptor subunit α | 84,417 | Antibody | Antagonist | true | 11.4 | pEC50 | 9,604 | OSE-127 | Antibody | false | null | 340,590,234 |
305 | catalytic_receptor | IL-2 receptor family | 2,301 | Interleukin-9 receptor | 77,149 | Agonist | Agonist | null | null | - | 5,000 | IL-9 | Peptide | false | null | 178,101,697 |
305 | catalytic_receptor | IL-2 receptor family | 2,305 | Thymic stromal lymphopoietin receptor | 77,151 | Agonist | Agonist | null | null | - | 5,083 | thymic stromal lymphopoietin | Peptide | false | null | 178,101,776 |
306 | catalytic_receptor | IL-3 receptor family | 1,707 | GM-CSF receptor, α subunit | 13,416 | Agonist | Agonist | null | null | - | 4,942 | GM-CSF | Peptide | false | null | 178,101,640 |
306 | catalytic_receptor | IL-3 receptor family | 1,707 | GM-CSF receptor, α subunit | 81,863 | Antibody | Binding | true | 9.86 | pIC50 | 7,785 | mavrilimumab | Antibody | false | null | 223,366,117 |
306 | catalytic_receptor | IL-3 receptor family | 2,309 | Granulocyte macrophage colony-stimulating factor receptor | 77,612 | Agonist | Agonist | null | null | - | 4,934 | G-CSF | Peptide | true | null | 178,101,632 |
306 | catalytic_receptor | IL-3 receptor family | 2,309 | Granulocyte macrophage colony-stimulating factor receptor | 77,176 | Agonist | Agonist | null | null | - | 4,942 | GM-CSF | Peptide | false | null | 178,101,640 |
306 | catalytic_receptor | IL-3 receptor family | 2,307 | Interleukin-3 receptor | 77,174 | Agonist | Agonist | null | null | - | 4,994 | IL-3 | Peptide | false | null | 178,101,691 |
306 | catalytic_receptor | IL-3 receptor family | 2,308 | Interleukin-5 receptor | 77,175 | Agonist | Agonist | null | null | - | 4,997 | IL-5 | Peptide | false | null | 178,101,694 |
306 | catalytic_receptor | IL-3 receptor family | 2,308 | Interleukin-5 receptor | 77,611 | Antagonist | Antagonist | null | null | - | 5,090 | YM90709 | Synthetic organic | false | null | 178,101,783 |
306 | catalytic_receptor | IL-3 receptor family | 1,705 | Interleukin 3 receptor, α subunit | 13,414 | Agonist | Agonist | null | null | - | 4,994 | IL-3 | Peptide | false | null | 178,101,691 |
306 | catalytic_receptor | IL-3 receptor family | 1,706 | Interleukin 5 receptor, α subunit | 80,175 | Antibody | Binding | false | 8.67 | pKd | 7,674 | benralizumab | Antibody | true | FDA (2017), EMA (2018) | 223,366,009 |
306 | catalytic_receptor | IL-3 receptor family | 1,706 | Interleukin 5 receptor, α subunit | 13,415 | Agonist | Agonist | null | null | - | 4,997 | IL-5 | Peptide | false | null | 178,101,694 |
307 | catalytic_receptor | IL-6 receptor family | 2,313 | Ciliary neutrophic factor receptor | 77,180 | Agonist | Agonist | null | null | - | 4,897 | ciliary neurotrophic factor | Peptide | false | null | 178,101,597 |
307 | catalytic_receptor | IL-6 receptor family | 2,313 | Ciliary neutrophic factor receptor | 77,613 | Agonist | Agonist | null | null | - | 6,150 | CRCF1/CLCF1 heterodimer | Peptide | false | null | 178,102,771 |
307 | catalytic_receptor | IL-6 receptor family | 2,311 | Interleukin-11 receptor | 77,178 | Agonist | Agonist | null | null | - | 4,976 | IL-11 | Peptide | false | null | 178,101,674 |
307 | catalytic_receptor | IL-6 receptor family | 2,311 | Interleukin-11 receptor | 79,029 | Agonist | Full agonist | true | null | - | 6,971 | oprelvekin | Peptide | true | FDA (1997) | 178,103,550 |
307 | catalytic_receptor | IL-6 receptor family | 2,316 | Interleukin-27 receptor | 77,617 | Agonist | Agonist | null | null | - | 6,151 | IL-27 | Peptide | false | null | 178,102,772 |
307 | catalytic_receptor | IL-6 receptor family | 2,312 | Interleukin-31 receptor | 77,179 | Agonist | Agonist | null | null | - | 4,995 | IL-31 | Peptide | false | null | 178,101,692 |
307 | catalytic_receptor | IL-6 receptor family | 1,710 | Interleukin-31 receptor, α subunit | 82,661 | Antibody | Binding | true | 8.7 | pKd | 8,720 | nemolizumab | Antibody | true | Japan (2022) | 252,827,378 |
307 | catalytic_receptor | IL-6 receptor family | 2,310 | Interleukin-6 receptor | 77,177 | Agonist | Agonist | true | 9.36 | pKd | 4,998 | IL-6 | Peptide | false | null | 178,101,695 |
307 | catalytic_receptor | IL-6 receptor family | 2,310 | Interleukin-6 receptor | 83,487 | Antibody | Binding | true | 8.85 | pKd | 9,093 | satralizumab | Antibody | true | Canada, Japan and FDA (2020), EMA (2021) | 315,661,178 |
307 | catalytic_receptor | IL-6 receptor family | 2,310 | Interleukin-6 receptor | 78,849 | Antibody | Binding | true | 8.6 | pKd | 6,881 | tocilizumab | Antibody | true | Japan (2005), EMA (2009), FDA (2010) | 178,103,463 |
307 | catalytic_receptor | IL-6 receptor family | 2,310 | Interleukin-6 receptor | 83,486 | Antibody | Binding | true | 12.72 | pKd | 8,363 | vobarilizumab | Antibody | false | null | 252,166,575 |
307 | catalytic_receptor | IL-6 receptor family | 1,708 | Interleukin-6 receptor, α subunit | 83,712 | Agonist | Agonist | true | 9.36 | pKd | 4,998 | IL-6 | Peptide | false | null | 178,101,695 |
307 | catalytic_receptor | IL-6 receptor family | 1,708 | Interleukin-6 receptor, α subunit | 81,886 | Antibody | Binding | true | null | pKd | 7,999 | sarilumab | Antibody | true | EMA & FDA (2017) | 249,565,679 |
307 | catalytic_receptor | IL-6 receptor family | 1,712 | Leptin receptor | 13,421 | Agonist | Agonist | false | 10.19 | pKd | 5,015 | leptin | Peptide | false | null | 178,101,712 |
307 | catalytic_receptor | IL-6 receptor family | 2,314 | Leukemia inhibitory factor receptor | 77,181 | Agonist | Agonist | null | null | - | 4,906 | cardiotrophin-1 | Peptide | false | null | 178,101,605 |
307 | catalytic_receptor | IL-6 receptor family | 2,314 | Leukemia inhibitory factor receptor | 77,182 | Agonist | Agonist | null | null | - | 5,016 | LIF | Peptide | false | null | 178,101,713 |
307 | catalytic_receptor | IL-6 receptor family | 2,314 | Leukemia inhibitory factor receptor | 77,183 | Agonist | Agonist | null | null | - | 5,035 | oncostatin M | Peptide | false | null | 178,101,731 |
307 | catalytic_receptor | IL-6 receptor family | 2,315 | Oncostatin-M receptor | 77,184 | Agonist | Agonist | null | null | - | 5,035 | oncostatin M | Peptide | false | null | 178,101,731 |
953 | catalytic_receptor | Immune checkpoint catalytic receptors | 1,874 | CD40 | 13,549 | null | null | null | null | - | 5,077 | CD40 ligand | Peptide | false | null | 178,101,770 |
953 | catalytic_receptor | Immune checkpoint catalytic receptors | 1,874 | CD40 | 84,845 | Antibody | Binding | true | 9.16 | pKd | 9,802 | CFZ533 | Antibody | false | null | 354,702,274 |
953 | catalytic_receptor | Immune checkpoint catalytic receptors | 1,887 | herpes virus entry mediator | 13,565 | null | null | null | null | - | 4,891 | B and T lymphocyte attenuator | Peptide | false | null | 178,101,591 |
953 | catalytic_receptor | Immune checkpoint catalytic receptors | 1,887 | herpes virus entry mediator | 13,563 | null | null | null | null | - | 5,070 | LIGHT | Peptide | false | null | 178,101,763 |
953 | catalytic_receptor | Immune checkpoint catalytic receptors | 1,887 | herpes virus entry mediator | 13,564 | null | null | null | null | - | 5,064 | lymphotoxin-α | Peptide | false | null | 178,101,757 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,736 | Interleukin-1 receptor-like 2 | 84,575 | Antibody | Antagonist | true | 10.62 | pKd | 9,665 | MAB92 | Antibody | false | null | 348,353,624 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,736 | Interleukin-1 receptor-like 2 | 88,895 | Antibody | Binding | false | 10.52 | pKd | 12,169 | spesolimab | Antibody | true | FDA and EMA (2022) | 472,319,291 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,905 | Interleukin-1 receptor, type I | 77,164 | Antagonist | Antagonist | null | null | - | 4,861 | AF12198 | Peptide | false | null | 178,101,562 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,905 | Interleukin-1 receptor, type I | 79,033 | Inhibitor | Inhibition | true | 7.82 | pKd | 6,972 | anakinra | Peptide | true | FDA (no history prior to 2001), EMA (2002) | 178,103,551 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,905 | Interleukin-1 receptor, type I | 77,163 | Antagonist | Antagonist | null | null | - | 5,878 | IL-1 receptor antagonist | Peptide | false | null | 178,102,502 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,905 | Interleukin-1 receptor, type I | 77,165 | Agonist | Agonist | null | null | - | 4,973 | IL-1α | Peptide | false | null | 178,101,671 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,905 | Interleukin-1 receptor, type I | 77,166 | Agonist | Agonist | null | null | - | 4,974 | IL-1β | Peptide | false | null | 178,101,672 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,905 | Interleukin-1 receptor, type I | 84,664 | Inhibitor | Inhibition | true | 10.52 | pKd | 9,704 | isunakinra | Peptide | false | null | 348,353,663 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,908 | Interleukin-18 receptor | 77,173 | Agonist | Agonist | null | null | - | 4,983 | IL-18 | Peptide | false | null | 178,101,680 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,908 | Interleukin-18 receptor | 77,609 | Agonist | Agonist | null | null | - | 6,149 | IL-37 | Peptide | false | null | 178,102,770 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,906 | Interleukin-33 receptor | 77,167 | Agonist | Agonist | null | null | - | 5,880 | IL-33 | Peptide | false | null | 178,102,504 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,907 | Interleukin-36 receptor | 77,170 | Antagonist | Antagonist | false | null | - | 5,879 | IL-36 receptor antagonist | Peptide | false | null | 178,102,503 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,907 | Interleukin-36 receptor | 77,168 | Agonist | Agonist | null | null | - | 5,881 | IL-36α | Peptide | false | null | 178,102,505 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,907 | Interleukin-36 receptor | 77,169 | Agonist | Agonist | null | null | - | 5,882 | IL-36β | Peptide | false | null | 178,102,506 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 1,907 | Interleukin-36 receptor | 77,172 | Agonist | Agonist | null | null | - | 5,883 | IL-36γ | Peptide | false | null | 178,102,507 |
312 | catalytic_receptor | Immunoglobulin-like family of IL-1 receptors | 2,969 | single Ig and TIR domain containing | 84,672 | Agonist | Agonist | false | null | - | 6,149 | IL-37 | Peptide | false | null | 178,102,770 |
760 | catalytic_receptor | Integrins | 2,577 | integrin α1β1 | 78,536 | Inhibitor | Inhibition | null | 9.1 | pIC50 | 6,581 | obtustatin | Peptide | false | null | 178,103,195 |